Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review. (Q37055015)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2007

edit

Language	Label	Description	Also known as
English	Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review.	scientific article published on January 2007

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18188838

retrieved

18 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Methodological approaches in the assessment of interferon-alfa-induced depression in patients with chronic hepatitis C - a critical review (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

main subject

patient

0 references

hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis C

1 reference

based on heuristic

inferred from title

chronic hepatitis

1 reference

based on heuristic

inferred from title

author

Hans-Ulrich Wittchen

series ordinal

2

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

author name string

Arne Schäfer

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

Jochen Seufert

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

Michael R Kraus

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

publication date

1 January 2007

1 reference

stated in

Europe PubMed Central

PubMed publication ID

18188838

retrieved

18 August 2017

published in

International Journal of Methods in Psychiatric Research

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

volume

16

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

issue

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

page(s)

186-201

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

cites work

An Inventory for Measuring Depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

A quantitative assessment of depression and thyroid dysfunction secondary to interferon-alpha therapy in patients with hepatitis C.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

Factors influencing the self-rating depression scale.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

Self-rating depression scale in an outpatient clinic. Further validation of the SDS.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1002%2FMPR.229

retrieved

21 January 2018

Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hepatitis C, interferon alfa, and depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression and anxiety in patients with hepatitis C: prevalence, detection rates and risk factors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurobehavioral effects of interferon therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side effects of therapy of hepatitis C and their management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of the depressive effects of interferon alfa therapy by the patient's initial affective state.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Longitudinal course of depression, fatigue, and quality of life in patients with high risk melanoma receiving adjuvant interferon

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression during therapy with interferon alpha--how long should an antidepressant treatment last?

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prophylactic SSRI during interferon alpha re-therapy in patients with chronic hepatitis C and a history of interferon-induced depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric complications of long-term interferon alfa therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A prospective study of neuropsychiatric symptoms associated with interferon-alpha-2b and ribavirin therapy for patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of hepatitis C among psychiatric patients in the public sector

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence of interferon alfa-induced depression in patients with chronic hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of chronic hepatitis C with recombinant interferon alfa. A multicenter randomized, controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychiatric side effects of interferon-beta in multiple sclerosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine for the prevention of depression induced by high-dose interferon alfa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression, anemia and health-related quality of life in chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-induced depression: prevalence and management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuropsychiatric adverse effects of interferon-alpha: recognition and management

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of interferon-alpha treatment of chronic hepatitis C on health-related quality of life

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Side effects of therapy for chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Central nervous system changes in hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The hospital anxiety and depression scale

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-induced depression: strategies in treatment.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening depressed patients in family practice. A rapid technic

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with interferon-α in patients with chronic hepatitis and mood or anxiety disorders

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suicidal impulses in patients with chronic viral hepatitis C during or after therapy with interferon alpha

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suicide associated with alfa-interferon therapy for chronic viral hepatitis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paroxetine for the prevention of depression induced by interferon alfa

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon Alpha-Induced Depression in Chronic Hepatitis C Patients: Comparison between Different Types of Interferon Alpha

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alpha-2a (40kD) [Pegasys] improves HR-QOL outcomes compared with unmodified interferon alpha-2a [Roferon-A]: in patients with chronic hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Emotional state, coping styles, and somatic variables in patients with chronic hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression from interferon therapy in patients with hepatitis C

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The phenomenology and treatment of interferon-induced depression.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of depression in cancer patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Manic episodes in two patients treated with interferon alpha

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global epidemiology of hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High prevalence and coinfection rate of hepatitis G and C infections in intravenous drug addicts

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression in the Normal Aged

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon treatment is not associated with a worsening of psychiatric symptoms in patients with hepatitis C.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of the psychiatrist in the care of patients with hepatitis C and HIV/AIDS.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurobehavioral effects of interferon-alpha in cancer patients: phenomenology and paroxetine responsiveness of symptom dimensions.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence-informed assessment and treatment of depression in HCV and interferon-treated patients

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Depression during interferon therapy for chronic viral hepatitis: early identification of patients at risk by means of a computerized test

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mood disorders associated with interferon treatment: theoretical and practical considerations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18188838

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1002/MPR.229

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

PMC publication ID

6878515

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

PubMed publication ID

18188838

1 reference

stated in

Europe PubMed Central

PMC publication ID

6878515

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6878515&resulttype=core&format=json

retrieved

13 May 2020

ResearchGate publication ID

5661676

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37055015&oldid=2243431042"